Project documents | Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799] | Guidance | NICE

Documents

A list of downloadable documents created during development.

Appeal

Appeal
Solving Kids' Cancer : Appeal letter 30 September 2016 462.92 KB
Solving Kids' Cancer : Scrutiny letter 30 September 2016 164.8 KB
Solving Kids' Cancer : Response to scrutiny letter 30 September 2016 449.47 KB
Solving Kids' Cancer : Final scrutiny letter 30 September 2016 152.51 KB
Solving Kids' Cancer : Written submission 03 October 2016 963.89 KB
Solving Kids' Cancer : Written submission 03 October 2016 236.03 KB
Solving Kids' Cancer : Written submission 03 October 2016 210.31 KB
Appeal decision 29 November 2016 306.47 KB

Final appraisal determination: 2

Final appraisal determination: 2
Final appraisal determination document 15 July 2016 397.88 KB
Committee papers 15 July 2016 2.96 MB

Appraisal consultation

Appraisal consultation
Committee papers 05 November 2015 7.59 MB
Appraisal consultation document 05 November 2015 411.75 KB

Invitation to participate

Final matrix 27 October 2015 127.91 KB
Final scope 13 February 2017 34.74 KB
Final matrix 13 February 2017 99.14 KB
Draft scope and provisional matrix comments table (post-referral) 13 February 2017 168.48 KB
Equality impact assessment (Scoping) 13 February 2017 173.76 KB

Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: draft scope for consultation (pre-referral) - November 2014

Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: draft scope for consultation (pre-referral) - November 2014 05 May 2015 104.95 KB

Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: provisional matrix (pre-referral) - November 2014

Neuroblastoma (high-risk) - dinutuximab (maintenance, after therapy) [ID799]: provisional matrix (pre-referral) - November 2014 05 May 2015 99.18 KB